Avizafone

This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C22H27ClN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65NK71K78P, chemically known as 2-benzoyl-4-chloro-2-((s)-2,6-diaminohexanamido)-n-methylacetanilide but generally known as avizafone, which bears US NIH Compound Identifier 71968. European Medicines Agency schedules Avizafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05616MIG. The term AVIZAFONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). AVIZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule avizafone under HS 29242995 and SITC 51479. As of Q4 2014, AVIZAFONE remains the US FDA Preferred Term for this commodity. Avizafone bears US NLM identifiers UMLS ID C0246215 and NCI Concept Code C72708. SMILES: CLC1CC(C(N(C(=O)CNC(=O)C(N)CCCCN)C)CC1)C(=O)C1CCCCC1.